Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bohlen

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|July 12, 1994
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporationH Bohlen, O Manzke, A Engert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Interleukin 10 inhibits cytokine production of human AML cellsF Westermann, D Kube, B Haier, et al.
International Journal of Cancer|February 8, 1995
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cellsJ Wolf, A Draube, H Bohlen, et al.
International Journal of Cancer|March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluationO Manzke, H Tesch, P Borchmann, et al.
FEBS Letters|March 27, 1999
Expression and a role of functionally coupled P2Y receptors in human dendritic cellsQ H Liu, H Bohlen, S Titzer, et al.
Blood|September 15, 1993
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodiesH Bohlen, T Hopff, O Manzke, et al.
Cancer Research|September 15, 1993
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodiesH Bohlen, O Manzke, B Patel, et al.
Journal of Dentistry|January 18, 2005
In vitro embryotoxicity assessment with dental restorative materialsS Schwengberg, H Bohlen, N Kleinsasser, et al.
International Journal of Cancer|October 9, 1995
Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in miceA Engert, C Gottstein, H Bohlen, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|July 12, 1994
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporationH Bohlen, O Manzke, A Engert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Interleukin 10 inhibits cytokine production of human AML cellsF Westermann, D Kube, B Haier, et al.
International Journal of Cancer|February 8, 1995
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cellsJ Wolf, A Draube, H Bohlen, et al.
International Journal of Cancer|March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluationO Manzke, H Tesch, P Borchmann, et al.
FEBS Letters|March 27, 1999
Expression and a role of functionally coupled P2Y receptors in human dendritic cellsQ H Liu, H Bohlen, S Titzer, et al.
Blood|September 15, 1993
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodiesH Bohlen, T Hopff, O Manzke, et al.
Cancer Research|September 15, 1993
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodiesH Bohlen, O Manzke, B Patel, et al.
Journal of Dentistry|January 18, 2005
In vitro embryotoxicity assessment with dental restorative materialsS Schwengberg, H Bohlen, N Kleinsasser, et al.
International Journal of Cancer|October 9, 1995
Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in miceA Engert, C Gottstein, H Bohlen, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
Pageof 7